Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKCA | AMGN | VRTX | REGN | BMY |
| Company | Akcea Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 18.15 | 277.69 | 402.95 | 900.00 | 44.36 |
| High | 18.17 | 278.63 | 404.07 | 943.77 | 44.42 |
| Low | 18.13 | 274.90 | 398.46 | 891.30 | 43.33 |
| Last | 18.17 | 278.39 | 400.16 | 937.61 | 43.70 |
| Change | +0.03 | +1.02 | -1.98 | +34.13 | -0.51 |
| % Change | +0.17% | +0.37% | -0.49% | +3.78% | -1.15% |
| Volume | 815,300 | 3,177,400 | 1,051,200 | 1,066,900 | 15,962,500 |
| 20-Day Average Volume | 661,490 | 2,279,350 | 1,004,185 | 509,390 | 14,313,960 |
| Previous Close | 18.14 | 277.37 | 402.14 | 903.48 | 44.21 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 18.14 | 270.20 | 398.71 | 909.16 | 47.83 |
| 20-Day Raw Stochastic | 70.59% | 92.43% | 48.36% | 83.62% | 4.40% |
| 20-Day Relative Strength | 73.10% | 53.70% | 46.36% | 54.16% | 27.45% |
| Weighted Alpha | -23.90 | +15.13 | +14.00 | +23.24 | -37.25 |
| Today's Opinion | 72% Buy | 16% Sell | 8% Buy | 48% Buy | 88% Sell |
| Previous Opinion | 64% Buy | 24% Sell | 8% Buy | 8% Buy | 88% Sell |
| Last Month's Opinion | 8% Buy | 8% Sell | 40% Buy | 56% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.22% since 10/02/20 | +3.34% since 04/25/24 | +0.62% since 04/25/24 | +5.27% since 04/25/24 | -2.24% since 04/25/24 |
| Low | 18.08 on 10/05/20 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 18.17 on 10/09/20 | 279.84 on 05/01/24 | 406.95 on 05/01/24 | 943.77 on 05/02/24 | 45.38 on 04/29/24 |
| 1-Month | |||||
| %Chg | +0.17% since 09/09/20 | +0.79% since 04/02/24 | -2.26% since 04/02/24 | -1.79% since 04/02/24 | -17.14% since 04/02/24 |
| Low | 18.05 on 09/21/20 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 18.22 on 09/28/20 | 279.84 on 05/01/24 | 414.95 on 04/03/24 | 962.20 on 04/04/24 | 52.87 on 04/03/24 |
| 3-Month | |||||
| %Chg | +36.72% since 07/09/20 | -13.86% since 02/02/24 | -5.77% since 02/02/24 | -0.80% since 02/02/24 | -10.29% since 02/02/24 |
| Low | 9.81 on 08/05/20 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 19.65 on 08/31/20 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +11.88% since 04/09/20 | +4.43% since 11/02/23 | +6.27% since 11/02/23 | +14.51% since 11/02/23 | -14.53% since 11/02/23 |
| Low | 9.81 on 08/05/20 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.33 on 05/02/24 |
| High | 19.65 on 08/31/20 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,846,054 | 148,774,592 | 103,936,712 | 99,167,768 | 89,618,088 |
| Shares Outstanding, K | 101,599 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 488,540,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | 40,770,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 22,380,000 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -49,580,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 1.45 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.49 on 08/04/20 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 11/03/20 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.69 | 29.23 | 23.70 | 41.85 |